3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
21
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Carcinoma, Neuroendocrine
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Ras-mutated Metastatic Colorectal Cancer
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma Metastatic
1
Neoplasms
1
Kidney Neoplasms
1
Histiocytosis
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Adenocarcinoma
1
Interventions
Doxorubicin
27
pembrolizumab
24
Radiotherapy
20
Cyclophosphamide
18
Magnetic Resonance Spectroscopy
17
Specimen Handling
14
Nivolumab
14
Ifosfamide
13
Gemcitabine
13
Biopsy
11
Surgical Procedures, Operative
10
Radiation
10
Temozolomide
9
X-Rays
8
Ipilimumab
8
pazopanib
7
fludarabine
7
cabozantinib
7
Irinotecan
7
Blood Specimen Collection
7
tazemetostat
6
liposomal doxorubicin
6
Trabectedin
6
Surveys and Questionnaires
6
Phantoms, Imaging
6
olaparib
5
eribulin
5
atezolizumab
5
Vincristine
5
Standard of Care
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
IFL protocol
×
1 year
×
Clear all
No trials found.